2012
DOI: 10.1016/j.tim.2012.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Guards of the great wall: bacterial lysozyme inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
107
1
4

Year Published

2014
2014
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 90 publications
(112 citation statements)
references
References 58 publications
0
107
1
4
Order By: Relevance
“…Antibacterial activity of EWL is due to its ability to disrupt the bonds between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) of the peptidgoglycan in bacterial cell walls (Callewaert et al, 2012;Lesnierowski & Kijowski, 2007). EWL is mostly active against Gram-positive bacteria, while Gramnegative bacteria are relatively resistant as the peptidoglycan layer of Gram-negative bacteria is protected by outer membrane compartment (Turner et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Antibacterial activity of EWL is due to its ability to disrupt the bonds between N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) of the peptidgoglycan in bacterial cell walls (Callewaert et al, 2012;Lesnierowski & Kijowski, 2007). EWL is mostly active against Gram-positive bacteria, while Gramnegative bacteria are relatively resistant as the peptidoglycan layer of Gram-negative bacteria is protected by outer membrane compartment (Turner et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Recently, it has been identified as one of the proteins with significant mycobactericidal activity from the pool of neutrophil granule proteins (18). Lysozyme inhibitors are important as they are essential for the survival of several pathogenic Gram-negative bacteria during infection in their animal hosts (19,20). In view of the antibacterial activity of lysozyme and because of the protection it endows at the cell surface, lysozyme inhibitors have been referred as the "guards of the great wall" (19) and thus are recognized as attractive targets for antibacterial drug design (21).…”
mentioning
confidence: 99%
“…The first of these to be identified was the E. coli Ivy (i.e., inhibitor of vertebrate lysozyme) protein (98) that inhibits only c-type lysozymes. Four other families of lysozyme inhibitors were subsequently identified; these differ in their localization (i.e., periplasmic [PliC] versus membrane bound [MliC]) and in their specificity for the different lysozyme types (i.e., c type, g type, or i type) (71).…”
Section: Discussionmentioning
confidence: 99%
“…The structural biology-derived prediction that both LipA and LipB were similar to bacterial lysozyme inhibitors also indicated that these proteins were likely localized to the periplasmic compartment in M. catarrhalis (71). To increase the likelihood of obtaining recombinant proteins that were folded properly, LipA and LipB were expressed as fusion proteins with a maltose-binding protein (MBP) that is secreted into the periplasm of E. coli.…”
Section: Fig 2 Growth Characteristics Of Wild-type M Catarrhalis Etsmentioning
confidence: 99%